Letters to the Editor

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia

Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen
Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto
Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen
Department of Radiology and Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Stanford, CA 94305
Department of Radiology and Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Stanford, CA 94305
Department of Radiology and Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Stanford, CA 94305
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen
Department of Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen
Hematology Division, Federal University of Minas Gerais, Belo Horizonte
Hematology and Hemotherapy Center, Centro de Hematologia e Hemoterapia, University of Campinas, Campinas
Hematology Division, Federal University of Paraná, Curitiba
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
Center for Cell-Based Therapy, University of São Paulo, Ribeirão Preto, Brazil; Laboratório de Investigação Médica (LIM) 31, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo
Haematologica Early view May 28, 2026 https://doi.org/10.3324/haematol.2025.288595